Colleen Cutcliffe, Ph.D., is the co-founder and CEO of Pendulum Therapeutics, a biotech company pioneering the next frontier of microbiome science. Leading a team of scientists with deep microbiology, biochemistry, computational and clinical expertise, Colleen is developing revolutionary, safe, and effective products that address imbalances in the microbiome, transforming people’s health. She has a Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and held senior positions at bioscience and pharmaceutical firms prior to starting Pendulum. In 2023, Colleen brought on Halle Berry, ...read more